Actinium Pharmaceuticals, Inc.(ATNM)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ATNM Actinium Pharmaceuticals, Inc.

已收盘 08-15 16:00:00 EDT

1.95

+0.01

+0.52%

盘后1.98

+0.03+1.54%

19:30 EDT

最高2.12	最低1.90	成交量86.02万
今开1.99	昨收1.94	日振幅11.08%
总市值6,075万	流通市值5,922万	总股本3,115万
成交额172.42万	换手率2.83%	流通股本3,037万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ATNM","market":"US","secType":"STK","nameCN":"Actinium Pharmaceuticals, Inc.","latestPrice":1.95,"timestamp":1723752000000,"preClose":1.94,"halted":0,"volume":860200,"hourTrading":{"tag":"盘后","latestPrice":1.98,"preClose":1.95,"latestTime":"19:30 EDT","volume":3496,"amount":6847.0522,"timestamp":1723764630333},"delay":0,"floatShares":30368737,"shares":31154376,"eps":-1.515641,"marketStatus":"已收盘","marketStatusCode":5,"change":0.01,"latestTime":"08-15 16:00:00 EDT","open":1.99,"high":2.115,"low":1.9,"amount":1724233.7393599998,"amplitude":0.110825,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.515641,"exchange":"AMEX","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1723795200000},"adr":0,"adjPreClose":1.94,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":2.01,"preClose":1.94,"latestTime":"09:15 EDT","volume":1979,"amount":3848.5783194,"timestamp":1723727717395},"postHourTrading":{"tag":"盘后","latestPrice":1.98,"preClose":1.95,"latestTime":"19:30 EDT","volume":3496,"amount":6847.0522,"timestamp":1723764630333},"volumeRatio":0.95757,"impliedVol":1.0973,"impliedVolPercentile":0.5794},"requestUrl":"/m/hq/s/ATNM","defaultTab":"news","newsList":[{"id":"2459701154","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 急速上涨6.96%报2.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459701154","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459701154?lang=zh_cn&edition=full","pubTime":"2024-08-16 00:32","pubTimestamp":1723739575,"startTime":"0","endTime":"0","summary":"北京时间2024年08月16日00时32分，Actinium Pharmaceuticals, Inc. 股票出现异动，股价急速拉升6.96%。Actinium Pharmaceuticals, Inc. 股票所在的生物技术行业中，整体涨幅为1.48%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发创新性靶向疗法。，目前在急性髓样白血病的临床试验中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816003256a1d47642&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816003256a1d47642&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATNM","BK4139"],"gpt_icon":0},{"id":"2459849824","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 大幅下跌5.00%报1.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459849824","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459849824?lang=zh_cn&edition=full","pubTime":"2024-08-15 03:25","pubTimestamp":1723663559,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日03时25分，Actinium Pharmaceuticals, Inc. 股票出现异动，股价急速跳水5.00%。Actinium Pharmaceuticals, Inc. 股票所在的生物技术行业中，整体跌幅为0.06%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发创新性靶向疗法。，目前在急性髓样白血病的临床试验中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815032559ab5db21b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815032559ab5db21b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATNM"],"gpt_icon":0},{"id":"2458981999","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 大幅下挫5.37%报1.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458981999","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458981999?lang=zh_cn&edition=full","pubTime":"2024-08-12 22:09","pubTimestamp":1723471743,"startTime":"0","endTime":"0","summary":"北京时间2024年08月12日22时09分，Actinium Pharmaceuticals, Inc. 股票出现波动，股价快速跳水5.37%。Actinium Pharmaceuticals, Inc. 股票所在的生物技术行业中，整体跌幅为0.78%。其相关个股中，Revance Therapeutics, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、60 Degrees Pharmaceuticals, Inc.涨幅较大，60 Degrees Pharmaceuticals, Inc.、Oragenics Inc.、Revance Therapeutics, Inc.较为活跃，换手率分别为311.69%、59.33%、35.11%，振幅较大的相关个股有60 Degrees Pharmaceuticals, Inc.、Oragenics Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为91.10%、40.71%、39.67%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发创新性靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240812220904aefe6c7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240812220904aefe6c7e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATNM","BK4139"],"gpt_icon":0},{"id":"2458990595","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 快速下跌5.81%报2.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458990595","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458990595?lang=zh_cn&edition=full","pubTime":"2024-08-09 21:30","pubTimestamp":1723210206,"startTime":"0","endTime":"0","summary":"北京时间2024年08月09日21时30分，Actinium Pharmaceuticals, Inc. 股票出现波动，股价快速下挫5.81%。Actinium Pharmaceuticals, Inc. 股票所在的生物技术行业中，整体涨幅为3.86%。其相关个股中，Mesoblast Ltd、Spero Therapeutics, Inc.、Novabay Pharmaceuticals, Inc.涨幅较大，Conduit Pharmaceuticals Inc.、Cns Pharmaceuticals, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为30.22%、5.01%、3.59%，振幅较大的相关个股有Zymeworks Inc.、Zyversa Therapeutics, Inc.、Zevra Therapeutics, Inc.，振幅分别为0.00%、0.00%、0.00%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发创新性靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809213006941ffbaa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809213006941ffbaa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATNM"],"gpt_icon":0},{"id":"2457316259","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 早盘股价大涨5.14%报2.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457316259","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457316259?lang=zh_cn&edition=full","pubTime":"2024-08-08 21:31","pubTimestamp":1723123917,"startTime":"0","endTime":"0","summary":"北京时间2024年08月08日21时31分，Actinium Pharmaceuticals, Inc. 股票出现波动，股价快速拉升5.14%。Actinium Pharmaceuticals, Inc. 股票所在的生物技术行业中，整体涨幅为1.03%。其相关个股中，Conduit Pharmaceuticals Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Anew Medical, Inc.涨幅较大，Anew Medical, Inc.、Conduit Pharmaceuticals Inc.、Aditxt, Inc.较为活跃，换手率分别为177.66%、172.25%、38.59%，振幅较大的相关个股有Conduit Pharmaceuticals Inc.、Anew Medical, Inc.、Generation Bio Co.，振幅分别为25.33%、15.60%、13.96%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发创新性靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808213157941ff724&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808213157941ff724&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATNM","BK4139"],"gpt_icon":0},{"id":"2457842074","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 急速下挫5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457842074","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457842074?lang=zh_cn&edition=full","pubTime":"2024-08-07 21:45","pubTimestamp":1723038356,"startTime":"0","endTime":"0","summary":"北京时间2024年08月07日21时45分，Actinium Pharmaceuticals, Inc. 股票出现波动，股价急速下挫5.56%。Actinium Pharmaceuticals, Inc. 股票所在的生物技术行业中，整体跌幅为0.72%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发创新性靶向疗法。，目前在急性髓样白血病的临床试验中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807214556aefdbaab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807214556aefdbaab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATNM"],"gpt_icon":0},{"id":"2457778172","title":"Actinium Pharmaceuticals, Inc. (Delaware)股价重挫73.74% 市值跌3557.88万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457778172","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457778172?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:31","pubTimestamp":1722864719,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时31分，Actinium Pharmaceuticals, Inc. 股票出现异动，股价急速下挫73.74%。Actinium Pharmaceuticals, Inc. 股票所在的生物技术行业中，整体跌幅为0.73%。其相关个股中，Zevra Therapeutics, Inc.、Cns Pharmaceuticals, Inc.、Okyo Pharma Ltd Com Npv 涨幅较大，Cns Pharmaceuticals, Inc.、Dermata Therapeutics, Inc.、Senti Biosciences, Inc.较为活跃，换手率分别为979.98%、34.90%、13.54%，振幅较大的相关个股有Cue Biopharma, Inc.、Compass Therapeutics, Inc.、Conduit Pharmaceuticals Inc.，振幅分别为12.33%、12.19%、11.60%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发创新性靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408052131599f106ec6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408052131599f106ec6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATNM","BK4139"],"gpt_icon":0},{"id":"2456430476","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 股价大跌5.20%报6.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456430476","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456430476?lang=zh_cn&edition=full","pubTime":"2024-08-01 23:38","pubTimestamp":1722526683,"startTime":"0","endTime":"0","summary":"北京时间2024年08月01日23时38分，Actinium Pharmaceuticals, Inc. 股票出现波动，股价快速下跌5.20%。Actinium Pharmaceuticals, Inc. 股票所在的生物技术行业中，整体涨幅为0.98%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发创新性靶向疗法。，目前在急性髓样白血病的临床试验中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801233803aefcb940&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801233803aefcb940&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATNM","BK4139"],"gpt_icon":0},{"id":"2455950444","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 急速跳水5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2455950444","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455950444?lang=zh_cn&edition=full","pubTime":"2024-07-31 00:16","pubTimestamp":1722356168,"startTime":"0","endTime":"0","summary":"北京时间2024年07月31日00时16分，Actinium Pharmaceuticals, Inc. 股票出现异动，股价大幅下挫5.36%。其相关个股中，Imunon, Inc.、Processa Pharmaceuticals, Inc.、Pharming Group Nv涨幅较大，Processa Pharmaceuticals, Inc.、Cns Pharmaceuticals, Inc.、Imunon, Inc.较为活跃，换手率分别为1879.83%、1399.28%、1206.07%，振幅较大的相关个股有Imunon, Inc.、Cns Pharmaceuticals, Inc.、Processa Pharmaceuticals, Inc.，振幅分别为78.15%、59.59%、55.88%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发创新性靶向疗法。，目前在急性髓样白血病的临床试验中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407310016099efe537e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407310016099efe537e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATNM"],"gpt_icon":1},{"id":"2455760661","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 早盘股价大跌5.12%报7.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2455760661","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455760661?lang=zh_cn&edition=full","pubTime":"2024-07-29 22:51","pubTimestamp":1722264670,"startTime":"0","endTime":"0","summary":"北京时间2024年07月29日22时51分，Actinium Pharmaceuticals, Inc. 股票出现波动，股价快速下跌5.12%。Actinium Pharmaceuticals, Inc. 股票所在的生物技术行业中，整体涨幅为0.52%。其相关个股中，Lipella Pharmaceuticals Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Nls Pharmaceutics Ltd.涨幅较大，Lipella Pharmaceuticals Inc.、Salarius Pharmaceuticals, Inc.、Nls Pharmaceutics Ltd.较为活跃，换手率分别为1955.73%、655.93%、204.54%，振幅较大的相关个股有Lipella Pharmaceuticals Inc.、Nls Pharmaceutics Ltd.、Anew Medical Inc C/Wts 21/06/2029 ，振幅分别为151.15%、75.11%、57.78%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发创新性靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240729225111af94a447&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240729225111af94a447&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATNM"],"gpt_icon":0},{"id":"2453058107","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 早盘股价大涨5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453058107","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453058107?lang=zh_cn&edition=full","pubTime":"2024-07-23 21:49","pubTimestamp":1721742549,"startTime":"0","endTime":"0","summary":"北京时间2024年07月23日21时49分，Actinium Pharmaceuticals, Inc. 股票出现波动，股价急速上涨5.15%。Actinium Pharmaceuticals, Inc. 股票所在的生物技术行业中，整体跌幅为0.05%。其相关个股中，Azitra Inc、Adial Pharmaceuticals, Inc、Salarius Pharmaceuticals, Inc.涨幅较大，Azitra Inc、Adial Pharmaceuticals, Inc、Salarius Pharmaceuticals, Inc.较为活跃，换手率分别为2442.45%、1506.26%、88.40%，振幅较大的相关个股有Azitra Inc、Adial Pharmaceuticals, Inc、Salarius Pharmaceuticals, Inc.，振幅分别为340.73%、94.31%、43.40%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发创新性靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240723214909941f9a5e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240723214909941f9a5e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATNM"],"gpt_icon":0},{"id":"2452161125","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452161125","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452161125?lang=zh_cn&edition=full","pubTime":"2024-07-17 23:43","pubTimestamp":1721231037,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日23时43分，Actinium Pharmaceuticals, Inc. 股票出现异动，股价快速跳水5.03%。Actinium Pharmaceuticals, Inc. 股票所在的生物技术行业中，整体跌幅为2.08%。其相关个股中，Aptevo Therapeutics Inc.、Geovax Labs Inc C/Wts 29/09/2025、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Aptevo Therapeutics Inc.、Aditxt, Inc.、Longeveron Inc.较为活跃，换手率分别为3068.81%、1332.22%、281.73%，振幅较大的相关个股有Aptevo Therapeutics Inc.、Aditxt, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 ，振幅分别为76.39%、46.25%、43.75%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发创新性靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717234358941f7f43&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717234358941f7f43&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATNM","BK4139"],"gpt_icon":0},{"id":"2450311205","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 早盘急速上涨5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450311205","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450311205?lang=zh_cn&edition=full","pubTime":"2024-07-12 22:23","pubTimestamp":1720794189,"startTime":"0","endTime":"0","summary":"北京时间2024年07月12日22时23分，Actinium Pharmaceuticals, Inc. 股票出现异动，股价大幅拉升5.28%。Actinium Pharmaceuticals, Inc. 股票所在的生物技术行业中，整体涨幅为1.43%。其相关个股中，Qualigen Therapeutics, Inc.、Zura Bio Limited C/Wts 、Instil Bio, Inc.涨幅较大，Qualigen Therapeutics, Inc.、Clearmind Medicine Inc.、Kazia Therapeutics Limited较为活跃，换手率分别为2113.98%、89.31%、43.16%，振幅较大的相关个股有Qualigen Therapeutics, Inc.、Surrozen Inc C/Wts 01/08/2031 、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 ，振幅分别为131.42%、48.15%、47.50%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发创新性靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407122223099681c681&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407122223099681c681&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATNM","BK4139"],"gpt_icon":0},{"id":"2449018347","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 股价大涨5.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449018347","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2449018347?lang=zh_cn&edition=full","pubTime":"2024-07-08 22:36","pubTimestamp":1720449398,"startTime":"0","endTime":"0","summary":"北京时间2024年07月08日22时36分，Actinium Pharmaceuticals, Inc. 股票出现异动，股价大幅拉升5.81%。Actinium Pharmaceuticals, Inc. 股票所在的生物技术行业中，整体涨幅为0.94%。其相关个股中，Virpax Pharmaceuticals, Inc.、Morphic Holding, Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Virpax Pharmaceuticals, Inc.、Cero Therapeutics Holdings, Inc.、Kineta, Inc.较为活跃，换手率分别为2173.53%、171.82%、139.75%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Fortress Biotech Inc 9.375% Cum Red Per Pref Ser A Usd25.00、Cero Therapeutics Holdings, Inc.，振幅分别为96.89%、46.35%、36.60%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发创新性靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407082236389681aad0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407082236389681aad0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATNM","BK4139"],"gpt_icon":0},{"id":"2449299775","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 早盘股价大跌5.22%报6.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2449299775","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2449299775?lang=zh_cn&edition=full","pubTime":"2024-07-05 23:05","pubTimestamp":1720191923,"startTime":"0","endTime":"0","summary":"北京时间2024年07月05日23时05分，Actinium Pharmaceuticals, Inc. 股票出现波动，股价急速跳水5.22%。Actinium Pharmaceuticals, Inc. 股票所在的生物技术行业中，整体涨幅为0.83%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发创新性靶向疗法。，目前在急性髓样白血病的临床试验中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240705230523941f4771&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240705230523941f4771&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATNM","BK4139"],"gpt_icon":0},{"id":"2441742534","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 快速下挫5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2441742534","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2441742534?lang=zh_cn&edition=full","pubTime":"2024-06-07 00:22","pubTimestamp":1717690940,"startTime":"0","endTime":"0","summary":"北京时间2024年06月07日00时22分，Actinium Pharmaceuticals, Inc. 股票出现波动，股价急速下挫5.05%。Actinium Pharmaceuticals, Inc. 股票所在的生物技术行业中，整体涨幅为0.36%。其相关个股中，Virax Biolabs Group Limited、Fibrobiologics, Inc.、Replimune Group, Inc.涨幅较大，Virax Biolabs Group Limited、Geovax Labs, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为2914.27%、82.42%、34.96%，振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Virax Biolabs Group Limited、Fibrobiologics, Inc.，振幅分别为129.76%、75.23%、70.00%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发创新性靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024060700222096812a59&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024060700222096812a59&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ATNM"],"gpt_icon":0},{"id":"2441788567","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 大幅拉升5.12%报8.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2441788567","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2441788567?lang=zh_cn&edition=full","pubTime":"2024-06-06 03:42","pubTimestamp":1717616567,"startTime":"0","endTime":"0","summary":"北京时间2024年06月06日03时42分，Actinium Pharmaceuticals, Inc. 股票出现波动，股价急速拉升5.12%。Actinium Pharmaceuticals, Inc. 股票所在的生物技术行业中，整体涨幅为1.22%。其相关个股中，Vigil Neuroscience, Inc.、Kineta, Inc.、Immatics N V C/Wts 01/07/2025 涨幅较大，Cns Pharmaceuticals, Inc.、Virios Therapeutics, Inc.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为159.02%、69.38%、54.18%，振幅较大的相关个股有Virios Therapeutics, Inc.、Kineta, Inc.、Celularity Inc C/Wts 16/07/2026 ，振幅分别为70.40%、63.28%、54.10%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发创新性靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240606034247af8c2e0e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240606034247af8c2e0e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATNM","BK4139"],"gpt_icon":0},{"id":"2437296057","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 早盘急速下挫5.76%报8.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2437296057","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2437296057?lang=zh_cn&edition=full","pubTime":"2024-05-22 21:54","pubTimestamp":1716386049,"startTime":"0","endTime":"0","summary":"北京时间2024年05月22日21时54分，Actinium Pharmaceuticals, Inc. 股票出现异动，股价急速下挫5.76%。Actinium Pharmaceuticals, Inc. 股票所在的生物技术行业中，整体涨幅为0.12%。其相关个股中，Sab Biotherapeutics Inc C/Wts 22/10/2026 、Mustang Bio, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025涨幅较大，Mustang Bio, Inc.、Biodexa Pharmaceuticals Plc、Coeptis Therapeutics Holdings, Inc.较为活跃，换手率分别为226.59%、115.17%、34.76%，振幅较大的相关个股有Mustang Bio, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Rezolute, Inc.，振幅分别为32.55%、23.65%、22.33%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发创新性靶向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024052221541087e89145&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024052221541087e89145&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATNM","BK4139"],"gpt_icon":0},{"id":"2435598205","title":"Actinium Pharma(ATNM.US)获Stephens &amp; Co.首次覆盖，给予增持评级, 目标价25.","url":"https://stock-news.laohu8.com/highlight/detail?id=2435598205","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2435598205?lang=zh_cn&edition=full","pubTime":"2024-05-14 17:54","pubTimestamp":1715680490,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["ATNM","BK4139"],"gpt_icon":0},{"id":"2434857977","title":"Actinium Pharmaceuticals, Inc. (Delaware)盘中异动 早盘急速跳水5.57%报8.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434857977","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2434857977?lang=zh_cn&edition=full","pubTime":"2024-05-10 22:25","pubTimestamp":1715351151,"startTime":"0","endTime":"0","summary":"北京时间2024年05月10日22时25分，Actinium Pharmaceuticals, Inc. 股票出现波动，股价快速下跌5.57%。Actinium Pharmaceuticals, Inc. 股票所在的生物技术行业中，整体涨幅为0.50%。Actinium Pharmaceuticals, Inc. 公司简介：Actinium Pharmaceuticals Inc是一家生物制药公司，致力于为缺乏有效治疗选择的癌症患者开发创新性靶向疗法。，目前在急性髓样白血病的临床试验中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051022255187e8721d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051022255187e8721d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ATNM","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.actiniumpharma.com","stockEarnings":[{"period":"1week","weight":-0.0762},{"period":"1month","weight":-0.7464},{"period":"3month","weight":-0.803},{"period":"6month","weight":-0.6954},{"period":"1year","weight":-0.7006},{"period":"ytd","weight":-0.6181}],"compareEarnings":[{"period":"1week","weight":0.0484},{"period":"1month","weight":-0.0317},{"period":"3month","weight":0.0285},{"period":"6month","weight":0.0886},{"period":"1year","weight":0.2277},{"period":"ytd","weight":0.144}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Actinium Pharmaceuticals, Inc.于1997年10月6日在内华达州注册成立。该公司曾是一家空壳公司，在市场上与合适的经营公司合并。该公司现在是一家生物制药公司，专注于抗癌药物的540亿美元的市场。该公司最先进的产品是Actimab -A ，含有AC-225抗体药物结构，目前在急性髓系白血病（AML）和Iomab-B——一种包含iodine131的抗体药物结构进行人体临床试验，用于造血干细胞移植时使用。该公司目前正在设计并申请一项造血干细胞移植的试验，主要针对老年患者难治的复发性急性髓系白血病。该公司正在利用其在放射免疫治疗领域的专业知识开发治疗癌症的药物。此外， AC-225为基础的药物开发依赖于专利的α粒子免疫治疗技术（ APIT ）平台，这是与Memorial Sloan Kettering癌症中心合作开发的技术，该中心的间接附属公司Actinium Holdings有限责任公司是制药公司的大股东。APIT技术与单克隆抗体结合时非常有效，但相对安全的α粒子会发射放射性同位素，尤其是锕225和铋213 ，最终药物结构的设计是专门针对并且杀死癌细胞，同时尽量减少副作用。该公司拟开发不同类型的癌症治疗产品，从与大型制药公司的合作和直接在专业市场销售其产品获得收益。","yearOnYearQuotes":[{"month":1,"riseRate":0.7,"avgChangeRate":0.050048},{"month":2,"riseRate":0.4,"avgChangeRate":-0.009843},{"month":3,"riseRate":0.1,"avgChangeRate":-0.087476},{"month":4,"riseRate":0.272727,"avgChangeRate":-0.045042},{"month":5,"riseRate":0.727273,"avgChangeRate":0.084309},{"month":6,"riseRate":0.181818,"avgChangeRate":-0.022588},{"month":7,"riseRate":0.363636,"avgChangeRate":-0.031624},{"month":8,"riseRate":0.181818,"avgChangeRate":-0.114045},{"month":9,"riseRate":0.5,"avgChangeRate":0.042952},{"month":10,"riseRate":0.6,"avgChangeRate":0.072278},{"month":11,"riseRate":0.4,"avgChangeRate":-0.037769},{"month":12,"riseRate":0.3,"avgChangeRate":-0.055118}],"exchange":"AMEX","name":"Actinium Pharmaceuticals, Inc.","nameEN":"Actinium Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Actinium Pharmaceuticals, Inc.(ATNM)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Actinium Pharmaceuticals, Inc.(ATNM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Actinium Pharmaceuticals, Inc.,ATNM,Actinium Pharmaceuticals, Inc.股票,Actinium Pharmaceuticals, Inc.股票老虎,Actinium Pharmaceuticals, Inc.股票老虎国际,Actinium Pharmaceuticals, Inc.行情,Actinium Pharmaceuticals, Inc.股票行情,Actinium Pharmaceuticals, Inc.股价,Actinium Pharmaceuticals, Inc.股市,Actinium Pharmaceuticals, Inc.股票价格,Actinium Pharmaceuticals, Inc.股票交易,Actinium Pharmaceuticals, Inc.股票购买,Actinium Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Actinium Pharmaceuticals, Inc.(ATNM)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Actinium Pharmaceuticals, Inc.(ATNM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}